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E N D O C R I N O L O G Y O F T H E H Y P O T H A L A M U S A N D T H E P I T U I T A R Y G L A N D * 
P E T E R C. SCRIBA 
IL Medizinische Klinik der Universität München, Munich, Federal Republic of Ge rmany 
At present, the endocrinology of the hypothalamus and the pituitary gland has two main 
aspects with respect to tumors of this region: (1) the Observation of endocrine Symptoms per-
mits the diagnosis of a tumor at an early stage, and (2) hormonal overproduction or defi-
ciency must be evaluated, since therapy by ablative or substitutive measures is of considerable 
impor tance for the well-being and life expectancy of these patients. 
P A T H O P H Y S I O L O G I C A L C O N S I D E R A T I O N S 
T h e rapidly growing information about the hormones of the hypothalamus and pituitary 
gland hasrecently been reviewed ina t ex tbook of pathophysiology (Scriba et al., 1972). Today , 
the blood levels of the hormones of the human anterior pituitary (Table I) are determined 
radioimmunologically. Determination of the levels of growth hormone ( G H ) and of the 
glycoproteohormones TSH, LH and FSH is most commonly carried out by endocrinologists. 
T h e structures of the human glycoproteohormones are not yet fully analyzed; their subunits 
a and ß (Table I) are just gaining at tention as pathogenic factors and for diagnostic questions, 
whereas the human pituitary Proteohormones , except for prolactin, have been synthesized. 
Since the posterior pituitary is the subject of further Communicat ions during this Conference, 
it may be permitted just to ment ion briefly the functional Separation of the secretion of anti-
diuretic hormone ( A D H ) and thirst. Table II gives a summary of dissociated and combined 
disturbances of A D H secretion and thirst. 
In recent years the concept of hypothalamic hypophyseotropic hormones has been introduced 
into clinical endocrinology. In Table III the releasing and inhibiting factors so far known are 
reported, together with the structures of 4 of these factors. Synthetic T R H (thyrotropin 
releasing hormone) and L H - R H (LH releasing hormone) have recently been employed for 
diagnostic and therapeutic purposes. 
The secretion of the hypophyseotropic hormones is itself influenced by hypothalamic 
catecholamines (neurotransmitters) . Kamber i et al. (1971) have shown by in vitro and in vivo 
experiments that dopamine stimulates LH secretion in rats via increased L H - R H secretion. 
In man L-dopa must be used since L-dopa, in contrast to dopamine , can cross the blood-brain 
barrier and serves as a precursor for dopamine and norepinephrine. Intravenous injection of 
L-dopa in patients does not increase the LH levels, as expected from animal experiments 
(Souvatzoglou et al., 1973). There is, however, a marked increment in growth hormone levels, 
presumably due to increased secretion of hypothalamic G R F after giving L-dopa intra-
venously. On the other hand, prolactin levels are diminished by L-dopa (Malarkey et al. , 
1971), apparently because of increased secretion of prolactin inhibiting factor (PIF) . With 
PIF deficiency increased prolactin secretion is observed (Turkington et al., 1971), as neuro-
surgeons are well aware from the galactorrhea that follows pituitary stalk section. 
In Figure 1 a scheme is given of the vertical functional relations between the groups of 
* Supported by the Deutsche Forschungsgemeinschaft (SFB 51). 
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TABLE I 
Human anterior pituitary hormones 
Symbol Name Molecular Amino acids Carbohy- Biological assay Normal* plasma values Plasma half-life 
weight drate Biological Radioimmuno-
(%> assay assay 
a. Proteohormones: ACTH Adrenocortico- 4600 39 — Corticosterone 0-5 LtU/ml < 1-50 pg/ml Exogenous 
t ropb hormone, secretion into (9 a.m.) (8-10 a.m.) 5-13 min; 
corticotropin theadrenal vein of hypophysecto-
mized rats 
endogenous longer 
ß-MSH Melanocytesti-mulating hormone 2700 22 
— Pigmentation of frog skin 
? 20-110 pg/ml 7 
HGH = Human growth 21500 190 — Epiphyseal ? < 1-5 ng/ml Endogenous 
STH hormone = somatotropin 
cartilage of 
tibia, hypophys-
ectomized rats 
50 min 
HPr Prolactin 22550 (ovine) 198 
— Pigeon crop 7 20-37 ng/ml 30 min 
h. Glycoproteohormones: * * * 
TSH Thyroid 25000 a 96 15 131I-secretion 166 LtU / m l 0.6-4.2 Exogenous 68 
stimulating (bovine) ß 113 of mouse thyroid ? fxU/ml min;endogenous 
hormone 90-130 min FSH Follicle 32000 7 15 Augmentation of — 4 mIU/ml** Initial phase 4 hrs 
stimulating (ovine) HCG effect on 
hormone rat ovaries 
LH = Luteinizing 30000 a 96 18 Ascorbic acid — 13 mIU/ml** Initial phase 
ICSH hormone = interstitial cell 
stimulating 
hormone 
(ovine) ß 120 depletion, ovaries 1-2 hrs 
* Normal plasma values depend on the deflnition of normal conditions: hour of the day, nutrition, age, sex and other factors have substantial influence?. 
** Values for normal young men in mlU IRP-2-HMG/ml serum; cyclic patterns are observed in women. 
*** Glycoproteohormones have two chemically different subunits (M ~ 15000). Recombination experiments revealed that TSH-a, FSH-a and LH-a may be 
substituted; therefore the ß subunits determine biological and immunological specificity. The amino acid sequences of LH-a, LH-ß (ovine), of TSH-a, 
TSH-ß(bovine) and the structure of the carbohydrate units of HCG-a and HCG-ß are published; the carbohydrate units of the glycoproteohormones are 
linked to aspartic acid. 
(From Scriba et al., 1972.) 
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TABLE II 
Disorders of ADH secretion and thirst 
ADH secretion Thirst Clinical manifestations 
Absent 
even after induction of hyper-
natremia by water deprivation 
Normal Classic diabetes insipidus 
(polyuria and polydipsia) 
Elevation 
of 'osmotic threshold' for ADH 
release 
Normal 'Diabetes insipidus', urinary 
osmolality increases only after 
marked hypernatremia 
Normal Decreased or absent Adipsia, 
hypernatremia without polyuria Elevation 
of 'osmotic threshold1 for ADH 
release 
Decreased or absent Hypernatremia, Syndrome of hypodipsia and 
ADH-reset 
Absent 
even in presence of hypernatremia 
Decreased or absent Severe hypernatremia without 
polyuria, adipsia 
Normal Increased, decreased osmotic 
threshold for thirst 
Primary polydipsia, 
psychogenic polydipsia has to be 
differentiated 
Inappropriately increased Normal Hyponatremia SIADH, Syndrome of inapprop-
riate ADH secretion 
(Schwartz-Bartter) 
(After Mahoney and Goodman, 1968.) 
TABLE III 
Hypophyseotropic hormones* - 'releasing factors' 
Hypophyseotropic hormone Structure 
C R F Corticotropin releasing factor 
MSH-RF = MSH releasing factor 
MIF = MSH inhibiting factor Pro-Leu-Gly-NH, 
G R F GH releasing factor Val-His-Leu-Ser-Ala-Glu-Glu-Lys-Glu-Ala? 
GIF GH inhibiting factor 
PRF = Prolactin releasing factor 
PIF = Prolactin inhibiting factor 
T R F Thyrotropin releasing factor pyro-Glu-His-Pro-NH2 
LRF LH releasing factor pyro-Glu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-GIy-NH8 
FRF FSH releasing factor 
* Instead of the abbreviation RF (releasing factor) RH may be used, e.g. TRH = thyrotropin 
releasing hormone. 
(From Scriba et al., 1972.) 
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Fig. /. Regulation of anterior pituitary hormone secretion. (From Scriba et al., 1972.) 
hormones briefly discussed above. Hypothalamic catecholamines and hypophyseotropic 
hormones , together with the glandotropic hormones of the anter ior pituitary, regulate the 
secretion of the peripheral target glands. The free, non-protein bound , i .e.biologicallyactive, 
component of the hormones of the peripheral target glands is the parameter regulated by the 
glandotropic hormones A C T H , TSH and gonadot ropins . Measurable alterations in the 
vertical hormonal axes serve for the regulation of the free peripheral hormones . 
Tumors of the hypothalamic-pitui tary region may lead to a deficiency in hypophyseotropic 
hormones, with consequent hypopitui tar ism, or alternatively may directly produce a deficient 
secretion of pituitary hormones with secondary insufficiency of the target glands (Fig. 1). In 
contrast to these forms of hypopituitarism in cases of inactive tumors , ho rmona l over-
production is found in hormonally active tumors: thus, the growth ho rmone excess of a 
pituitary adenoma causes acromegaly, while hamar tomas of the tuber cinereum may produce 
pubertas praecox by increased L H - R H secretion. 
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D I A G N O S T I C I M P L I C A T I O N S O F TESTS F O R H Y P O T H A L A M I C 
A N D P I T U I T A R Y F U N C T I O N 
This section briefly reviews the information which neurosurgeons may obta in from examina-
tion of hypotha lamic and pituitary function. Table IV summarizes horizontally the site of 
action and vertically the effective scope of the endocrinological methods . 
In clinically evident hypopituitarism the determination of basal levels of pituitary and target 
gland ho rmones will not always reveal subnormal values. This is for methodological reasons, 
since the analytical procedures do not always permit a distinction between the wide normal 
ranges of controls and the lowered values of these patients. Thus, in cases of complete or 
incomplete 'panhypopi tu i ta r i sm\ normal or subnormal basal hormone levels may be found. 
Therefore, as a general endocrinological rule, Stimulation tests are employed for the diagnosis 
of insufficiency states and suppression tests for hormonal overproduction states. 
St imulat ion tests are available for the examinat ion of disorders of the hypothalamic-
pituitary region. These act on the site of the hypothalamus and o n the anterior pituitary. The 
technical problems of all these tests have recently been discussed at length in the endocr ino-
logical tex tbook of Labhar t (1971) and will not be dealt with here. As a first example the 
Insulin hypoglycemia fest (Table IV) will be mentioned, in which the control person reacts 
with an increased secretion of growth hormone . This test is of particular value in the diagnosis 
of pituitary insufficiency, as discussed by Fahlbusch during this meeting (pp. 90-95). The 
same procedure, the insulin hypoglycemia test, also provides a means to test the CRF-ACTH-
cortisol axis and to assess the ability of a patient to tolerate stressful situations. 
A decreased response to this test may be due to an insufficiency at one or more of the levels 
mentioned, namely hypothalamus, adenohypophysis or adrenal gland. In this case lysin-
vasopressin is used as a cort icotropin releasing factor ( C R F ) for further eludication. A 
positive response to lysin-vasopressin, i.e. increase of radioimmunologically determined 
A C T H levels or of Cortisol levels, reveals intact cort icotropic function of the adenohypophys i s 
and locates the disorder in the suprasellar region. Lysin-vasopressin may also be used for the 
differential diagnosis of Cushing's Syndrome, since no response is found in cases caused by 
adrenal tumors in contrast to cases of hypothalamic-hypophyseal origin (Scriba et al., 1972). 
The CRF-ACTH-cor t i so l axis is, however, only of limited value for the diff'erentiation 
between hypothalamic and hypophyseal disorders, since only a small proport ion of patients 
with tumors in the hypothalamic-hypophyseal region have secondary adrenal insufficiency. 
In the next axis (Table IV) synthetic T R H is used for the Stimulation of TSH secretion by the 
adenohypophysis . This test provides information about the suprasellar extension of pituitary 
tumors (Pickardt et al., This Volume, pp . 105-107). However, n o means yet exist for specifically 
st imulating the secretion of endogenous T R H , as anti thyroidal drugs - and other inhibitors 
as well, e.g. Metopirone (Table IV) - act on the adenohypophysis and the hypothalamus 
simultaneously. Synthetic L H - R H has recently been employed to st imulate the secretion of 
both gonadotropins (LH, FSH) at the pituitary level, whereas Clomifene apparently acts via 
increased secretion of hypothalamic endogenous L H - R H . The Clomifene Stimulation test has , 
however, the disadvantage of a lag time of some days (Souvatzoglou, personal communica-
tion). 
After these considerations we have briefly to come back to the tests for secretion of the 
directly acting adenohypophyseal hormones G H and prolactin. In addit ion to the insulin 
hypoglycemia test (La.) it is possible to st imulate growth hormone secretion at the hypothala-
mic level using intravenous L-dopa injection (Souvatzoglou et al., 1973), which at the same 
time lowers the prolactin levels (La. ) . Since T R H stimulates the secretion of prolactin as well 
as of T S H , the former hormone may be checked at both the hypothalamic and the adenohypo-
physeal level. 
The aims of endocrinological examination of patients with hypopituitarism may be summa-
rized as follows: 
1. Detection of hormonal deficiencies and estimation of the necessary substitutive therapy. 
2. Assessment of stress tolerance. 
3. Differentiation of hypothalamic and adenohypophyseal hypopituitarism. 
4. Differentiation of primary and secondary insufficiency of target glands. 
5. Stimulation tests at the hypothalamic and hypophyseal levels may in addit ion provide 
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TABLE IV 
Site of action and effective scope of endocrinological methods for the investigation of hypothalamic and pituitary disorders 
1. Basal hormone levels 
Determination of (glandotropic) anterior 
pituitary hormones 
Determination of peripheral hormones 
2. Stimulation tests 
Stimulation of the axis hypothalamus-
pituitary-peripheral gland 
Withdrawal of peripheral hormones = 
Stimulation of hypothalamus-pituitary 
Stimulation of the anterior pituitary with 
hypophyseotropic hormones 
Stimulation of peripheral glands with 
glandotropic hormones 
3. Suppression tests 
Hypothalamus-pituitary 
ACTH TSH 
Cortisol Thyroxine, 
(circadian rhythm!) triiodothyronine 
LH, FSH 
Testosterone, 
estrogens, 
progesterone 
Clomifene 
Growth hormone Prolactin 
Insulin — Insulin, hypo- Phenothiazine f 
hypoglycemia glycemia, arginine, L-dopa \ 
L-dopa 
Metopirone Antithyroid drugs (Anti-androgen) — — 
Lysin-vasopressin TRH 
(as CRF) 
ACTH 
Stimulation test 
TSH 
Stimulation test 
LH-RH 
HCG 
Stimulation test 
TRH 
Dexamethasone T3 suppression test — Oral glucose tolerance test (Ergot-alkaloids) 
(From Scriba et al., 1972.) 
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information about the suprasellar extension of pituitary tumors . 
Finally, suppression tests must briefly be mentioned (Table IV), as these are used in cases with 
hormonal overproduction (Fahlbusch, This Volume, pp . 90-95). Oral glucose tolerance tests 
suppress growth hormone secretion in normals and in chemical diabetes. In view of the multi-
plicity of factors that st imulate growth ho rmone secretion (Scriba et al., 1972), and taking 
borderline cases into account , the G H suppression test by oral glucose loading is of impor tance 
in the diagnosis of acromegaly. Absent or paradoxical G H responses to the tests (oral glucose 
tolerance, arginine tolerance, insulin hypoglycemia) demonst ra te the functional au tonomy 
of growth hormone producing adenomata of the adenohypophysis . In general, these tests are 
of particular importance for the assessment of the success of therapeutic measures in cases of 
hormonally active tumors . 
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